Despite being critical to models of coordinated care, the relationship and communication between primary care providers (PCPs) and cancer specialists throughout the cancer continuum is poorly understood. Using pre-defined search terms, we conducted a systematic review of the literature in three databases to examine the relationship and communication between PCPs and cancer specialists. Among 301 articles identified, 35 met all inclusion criteria and were reviewed indepth. We integrated findings from qualitative, quantitative, and disaggregated mixed methods studies using meta-synthesis. Six themes were identified and incorporated into a preliminary conceptual model of the PCP-cancer specialist relationship: (1) poor and delayed communication between PCPs and cancer specialists, (2) cancer specialists' endorsement of a specialist-based model of care, (3) PCPs' belief that they play an important role in the cancer continuum, (4) PCPs' willingness to participate in the cancer continuum, (5) cancer specialists' and PCPs' uncertainty regarding the PCP's oncology knowledge/experience, and (6) discrepancies between PCPs and cancer specialists regarding roles. These data indicate a pervasive need for improved communication, delineation and coordination of responsibilities between PCPs and cancer specialists. Future interventions aimed at these deficiencies may improve patient and physician satisfaction and cancer care coordination.
INTRODUCTION
Poor coordination and communication between primary care providers (PCPs) and specialist physicians contributes to avoidable patient morbidity and mortality, fragmented care and increased costs [1, 2] . Despite intense focus on the quality and safety of cancer care during the last 15 years, the ways in which cancer specialists interact and communicate with PCPs has largely escaped attention. In the Institute of Medicine's (IOMs) 2005 report From Cancer Patient to Cancer Survivor: Lost in Transition, coordination between specialists and PCPs was listed as one of four key components of survivorship care [3] , but recommendations for how these physicians should interact during the cancer care continuum -including diagnosis, treatment, surveillance and palliation-were lacking.
Multiple models for the PCP-specialist physician relationship have been previously described including primary care-based, shared-care and specialist-based models [4] . These models have been investigated more thoroughly for diseases such as diabetes where clinical management of the disease is often chronic and within the scope of primary practice [5, 6] . While a limited number of studies have examined shared-care models in cancer survivorship, it is uncertain whether these models are feasible or accepted throughout the cancer care continuum where treatment episodes may be time-limited or incompletely understood by the PCP [7, 8] . A specialist-based model entails provision of care by cancer specialists for most issues that arise during cancer treatment and the initial post-treatment surveillance periods, including those that may fall within the scope of primary practice. However, the growing number of cancer survivors [9] , the projected shortage of cancer specialists [10] , and the increasing complexity of cancer patients with respect to age and comorbidities all challenge assumptions about the effectiveness of a specialist-based model as optimal for value, quality and coordinated care [11, 12] . A fundamental component of any of these models of care and the PCP-specialist relationship is communication, and the frequency, quality and ideal means of communication between PCPs and cancer specialists is poorly understood.
Our objective was to describe the attributes of the relationship and communication between PCPs and cancer specialists. We performed a systematic review of the literature and a metasynthesis of qualitative, quantitative, and disaggregated mixed methods studies. We summarized the literature with regard to key themes relating to the PCP-cancer specialist relationship throughout the cancer care continuum to determine what is currently known, to inform a preliminary conceptual model, to expose relevant gaps in knowledge, and to make recommendations for future work.
MATERIALS AND METHODS

Data Sources and Searches
In November 2015, we initiated a search of the published literature using PubMed, MEDLINE and EMBASE databases for articles published between January 1, 2000 and October 31, 2015 . As a first step, we broadly searched terms and synonyms for cancer specialist, primary care physician, communication and relationships and then built a search string that captured the keyword search terms (see supporting information). Next, we limited the search to studies that related to cancer care including diagnosis, treatment, palliation and survivorship. Searches were limited to English language articles. All publications were then combined into a single list and duplicates were excluded for review.
Study Selection
We reviewed abstracts and excluded studies that described the physician-patient relationship or communication, studies that addressed cancer screening in the general population, the relationship or communication between PCPs or cancer specialists and other members of the health care team (nurses, pharmacist, managers), and comparisons of how PCPs or cancer specialists treat specific conditions ( Figure 1 ). During data abstraction we elected to exclude studies that only reported on the patient perspective of the PCP-cancer specialist relationship. Our rationale for excluding these articles was that our original search terms did not include terms representing patients and we were not confident that our search had encompassed the entirety of articles that would represent the patient's perspective. We also felt the patient perspective, attitudes and preferences related to this relationship represented a significantly large and distinct topic as to be beyond the scope of this review. We supplemented our automated search by manually searching the bibliographies of included studies.
We developed inclusion and exclusion criteria for the systematic review, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) schema [13] . Studies were excluded if they contained no data about cancer diagnosis, treatment or survivorship or no data about the relationship or communication between PCPs and cancer specialists. Both quantitative and qualitative studies were eligible for inclusion. One reviewer (L.A.D) assessed abstracts to ensure alignment with inclusion/exclusion criteria ( Figure 2 ). In the second round of the review, at least 2 reviewers independently reviewed the remaining full text publications to verify eligibility (L.A.D, J.N.H. or G.P.Q.). After discussing discrepancies and reaching consensus and adding articles identified from hand-searching the references of eligible publications, the final set of eligible publications for data abstraction was identified.
Data Abstraction
We developed a data abstraction tool that captured detailed data from both quantitative and qualitative studies; these included study design, main variables, statistical analysis, results and conclusions. For mixed methods studies, data was abstracted for both the quantitative and qualitative components and meta-inferences were used. Data were abstracted independently and in duplicate, and a third methodologist resolved disagreements.
Risk of Bias and Quality of the Studies
Methodological quality was assessed among quantitative and qualitative studies, and in the case of mixed methods designs, assessed independently for each portion of the study. We evaluated each quantitative study according to six criteria: assessment of reliability, validity and quality, minimization of selection and attrition bias where applicable, minimization of confounding, minimization of measurement bias, statistical tests, and whether or not the conclusions were supported by the results. We evaluated qualitative studies according to six separate criteria: assessment of reliability, validity and quality, sampling strategy, data reduction methods and data analysis, final themes with definitions, validation of results, and strategies for adjudication of discrepancies between coders.
Analysis
Thematic analysis was used to synthesize the quantitative and qualitative evidence into coherent themes [14] . As described in previous meta-synthesis of qualitative and quantitative studies [15] , this technique specifically calls for integration of qualitative and quantitative data at the analysis and interpretation phases. We used an inductive approach, allowing the data content to direct the analysis. Each publication was read and reviewed in-depth. The data were then independently coded by at least two investigators and searched for significant themes related to the communication or relationship between PCPs and cancer specialists. The reviewers then discussed, compared and contrasted the themes across studies for further refinement until consensus was reached. In each case, consensus was reached and further adjudication was not necessary.
RESULTS
Our initial search identified 301 citations, of which 43 were potentially eligible for inclusion. The reasons for exclusion are summarized in Figure 2 . After complete review and data abstraction, 36 studies met all inclusion criteria [12, . Among eligible studies, 23 (64%) were quantitative surveys, 11 (30%) were qualitative studies, and 2 (6%) used mixed methods. The study subjects included PCPs and a variety of cancer specialists (Table 1) . Among studies that included cancer specialists, 89% (n=17/19) included medical oncologists; only 31% (n=6/19) included radiation oncologists and only 16% (n=3/19) included surgeons or surgical oncologists. The majority of studies addressed survivorship only (n=26, 72%), while the remaining addressed the relationship or communication between PCPs and cancer specialist during other phases of cancer care. Most of the studies letters from oncologists to PCPs, only 20% contained information regarding prognosis, 55% described what the patient was told, and only 10% included when or how to contact the oncologist [25] .
Survivorship Communication-In one study, only 56% of PCPs involved in cancer survivorship reported that the specialist communicated transfer of survivorship care to the PCP [21] , a finding that was supported in another study in which 56-62% of PCPs indicated that transfer communication was infrequent [46] . Several studies looked specifically at how discharge letters or survivorship care plans (SCPs) impacted communication between PCPs and cancer specialists [22, 27, 29, 31] . In one study, 89% of oncology providers felt it was very important for PCPs to receive SCPs, but 38% did not feel it was their responsibility to provide these plans [36] . In another study, only 14% of cancer specialists reported providing care plans to PCPs, citing limited training, no available template and a lack of reimbursement as barriers to this particular form of communication [38] . SCPs were generally a desired form of communication by PCPs. In one survey, 88% of PCPs believed that electronic medical record (EMR) generated SCPs were useful in coordinating care [22] . In another study, 85% of PCPs believed SCPs helped them to understand their roles.
Strategies used by PCPs to overcome inadequate communication-In some situations when communication was inadequate
PCPs reported that they relied on the patient for updates [26, 27] . PCPs also described a strategy of re-referral of the patient to the cancer specialist when a question arose, given the reported difficulty in speaking directly with cancer specialists [39] .
Factors Enhancing Communication-Five studies identified conditions that facilitated satisfactory communication [18, 26, 28, 39, 50] . One described a Canadian centralized cancer care system with synoptic discharge communication in which PCPs were satisfied with discharge communication from oncologists [18] . In another study of PCPs, communication from oncologists was variable, but improved when the PCP and oncologist had a pre-existing relationship and practiced in the same health care system [26] . In a study of PCPs and cancer specialist in a Veterans Administration (VA) system, communication was enhanced by an integrated EMR though these same providers reported difficulty communicating with providers external to the hospital and EMR system [28] . PCPs that reported satisfaction with cancer specialists communication typically also reported ease of reaching cancer specialists by phone or email [39] . In a randomized trial in Australia, PCPs an increase in confidence and satisfaction with communication was noted among PCPs receiving faxed tailored chemotherapy information as compared to those PCPs receiving usual correspondence [50] .
Cancer specialists' endorsement of a specialist-based model of care
A number of studies described cancer specialists' preference for a specialist-based model of care [19, 27, 28, 32, 34, 37, 44, 45] . In one study, 50% of medical oncologists reported serving as the PCP for at least 25% of their patients (but without specific mention of what specific primary care service were provided) [32] . In another study, oncologists endorsed their preference for specialist-based care because they believed patients were not well 
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Author Manuscript enough to go to multiple physicians [28] . The preference for a specialist-based model extended into survivorship care with 44% of breast cancer specialists in one survey stating that a breast surgeon should always be involved in breast cancer survivorship [44] . Cancer specialists also expressed uncertainty about the appropriateness of PCP-based survivorship care and this uncertainty seemed to influence practice patterns [34, 45] . In one study of oncologists' practice related to survivorship care, oncologists admitted that they rarely discharged cancer survivors to PCPs for surveillance and survivorship, instead monitoring patients indefinitely [27] . Oncology providers indicated that they felt this long-term commitment provided patients with reassurance that any potential problems would be detected as early as possible. Other specialists desired to remain involved with survivors because patient contact provided positive reinforcement of the success of their therapy. In one qualitative study, oncology specialists stated that they struggled with discharging survivors because of the bonds they had established with patients and their concern for survivors needs. They reported becoming "emotionally invested" in the success of the patient and wanted to remain involved even after the completion of active treatment [37] . While specialists often acknowledged the role of the PCP in addressing health concerns, they viewed cancer care as a "special domain" and acknowledged being protective and possessive of some patients. In another study, oncologists reported treating minor problems within the scope of primary practice because of uncertainty regarding the PCPs willingness or ability to address such problems [19] .
PCPs belief that they play an important role in the cancer continuum
PCPs believed they played an important role during cancer care, specifically with regard to providing moral support, education, and management of medical issues that arose during cancer care [23, 24, 27, 28, 33, 39, 42] . They characterized their care as philosophically different from that of the oncologists and as "balancing" the oncologists' approach. Specifically, PCPs noted that they were "oriented toward the whole person", rather than focusing on "just their cancer." PCPs also thought that cancer specialists excluded them because the PCPs might be less willing to support aggressive cancer treatments in patients with poor prognoses [23] . In one study, PCPs reported that patients viewed them as trusted experts and described patients' elicitation of the PCPs opinion on recommendations regarding treatments and therapies before initiation of the treatments prescribed by the cancer specialist. They described patients' reliance on the PCP to manage symptoms, interpret information presented by the cancer specialist and to help patients make sense of their personal experience of cancer [33] . In one survey, 80% of PCPs felt they were positioned better than cancer specialists to provide psychosocial support to their patients, and that because of this, they should be involved throughout the cancer care continuum [42] .
PCPs' desire and willingness to play a role in the cancer continuum
PCP views about timing of involvement-PCPs expressed a desire to remain involved in all phases of the cancer continuum and expressed frustration with the lack of interaction with patients undergoing active treatment [29] . They described their efforts to maintain good relationships with patients, but also felt oncologists "swallow[ed] up" the patient by providing primary as well as cancer care. PCPs complained that some patients only visited after an oncologist refused to perform a procedure such as a Pap smear, leaving them feeling exploited and "shut out" [23] . In some situations, PCPs believed patient preferences contributed to the specialist-based model with 65% of PCPs in one study stating that the patient's desire for specialist care was a barrier to PCP involvement [21] . Only one study reported PCP ambivalence about assuming a larger role, despite these PCPs feeling capable of assuming the role if necessary [37] .
PCP role in survivorship-PCPs were especially willing to participate during the survivorship phase [12, 21, 23, 29, 33, 39-42, 46, 49] . In a survey of PCPs who had attended a refresher course on care of adult survivors of childhood cancer, 97% of PCPs indicated that they were willing to participate in shared care of these patients, and 64% felt it was their responsibility to be in charge of survivorship care [12] . In one study of PCPs, 32% believed that they should be involved at an earlier phase of follow-up of breast cancer patients and 40% were willing to accept exclusive responsibility for follow-up earlier than 5-years after active treatment. Nineteen percent (19%) were willing to assume follow-up immediately after active treatment [21] . PCPs ready to assume exclusive responsibility for survivorship care 2-3 years after active treatment identified several modalities that would ease this transition including a patient-specific letter from the specialist, printed guidelines, expedited access to investigations when recurrence was suspected, and expedited re-referral if necessary [42] .
Specialists and PCPs are uncertain of the PCPs knowledge or training to provide care
Despite PCPs' willingness to participate in the cancer care continuum, cancer specialists expressed skepticism that PCPs were trained to provide this care [19, 20, 45] . In one study, oncologists reported treating problems within the scope of a PCPs practice because of uncertainty regarding the PCPs' competence to address such problems [19] . In another study, only 23% of oncologists believed that PCPs had the skills to conduct appropriate testing for breast cancer recurrence and only 38% believed PCPs could care for late effects of breast cancer and breast cancer treatment [20] . A further study of breast cancer specialists cited concerns for a lack of PCP experience or training in oncology as barriers to discharge for follow-up; they indicated that increased education and training, development of shared protocols and recruitment of primary care based oncology nurses would facilitate early discharge to PCPs [45] .
PCPs mostly endorsed this uncertainty and lack of knowledge or training [17-21, 29, 33, 37, 43, 46, 49, 50] . Insufficient knowledge of cancer issues was cited as a barrier to providing survivorship care by 58% of PCPs in one study [17] and 79% in another [29] . In one study, PCPs felt uncomfortable with patient's questions about their cancer diagnosis and described a lack of knowledge regarding current treatment protocols [33] . A group of PCPs treating breast cancer survivors expressed a lack of confidence in managing lymphedema, family planning and psychosocial counseling [18] . With regards to colorectal cancer survivorship care, PCPs desired knowledge regarding genetic counseling and testing, increased risks for second colorectal cancers, and other cancers and diseases [43] . In one study, PCPs relied on the Internet to stay current and to answer patient questions [33] .
that PCPs ask patients for information (which may erode trust in the healthcare system) or use re-referral as a strategy to overcome difficulty in directly communicating with cancer specialists. These strategies may be both inaccurate and inefficient. We did note several circumstances associated with satisfactory or enhanced communication including the use of a shared EMR (such as in the Veterans Administration health system) and direct communication access to cancer specialists by PCPs (personal phone or email). Some cancer systems now allow access to electronic health portals for referring physicians and patients. These systems may help address communication gaps, but these portals were not considered in any of the identified studies. It is uncertain how PCPs use these system, and the use of and satisfaction with these systems remains an area for further investigation. Outside of integrated health systems, cancer specialists do not typically have access to primary care records.
Intervention strategies aimed at improving and facilitating the quality of communication between PCPs and cancer specialists may improve patient and provider satisfaction, while reducing duplication (laboratory or imaging tests) or omission of important services (psychological support or management of co-morbidities). We recommend ( Figure 4 ) that cancer specialists aim to make personal contact with PCPs after initial referral, to report major changes in a patient's course, and at discharge. When possible cancer specialists should share direct contact information (personal mobile number or email address) with PCPs to facilitate timely communication and perhaps avoid the need for re-referral. Cancer centers and specialists must also emphasize (and delineate responsibility for) the provision of a SCP to the PCP at discharge. This mode of communication was nearly unanimously viewed as helpful by PCPs, providing justification to address the identified barriers to this mode of communication for the cancer specialist (cancer specialist's lack of training in preparing SCPs and a lack of reimbursement). PCPs need to know what to watch for, when to refer back to the cancer specialists, and that cancer specialists will respond in a timely way when patients are re-referred.
Beyond improved communication, there is a need for recognition and delineation of physician roles throughout the cancer care continuum that considers the necessary contributions of both the PCP and cancer specialists and avoids duplication or omission in important services. In the reviewed literature, cancer specialists expressed a preference for a specialist-based model where they provide active treatment, surveillance, palliative and survivorship care, and in some cases provide services that would normally fall within the scope of primary practice. This preference seemed to be motivated by three factors-(1) a belief that the patient was too ill to visit multiple physicians, (2) an obligation to the patient rooted in the belief that PCPs were ill-equipped to provide care, and/or (3) personal fulfillment in continuing to see patients during the survivorship phase. PCPs did not prefer a specialist-dominated model, especially during the advanced cancer/palliative and survivorship phases of care [20] . Excluding or not engaging the PCP during active treatment fails to capitalize on the patient-PCP continuity relationship and potentially erodes this relationship in a way that could have implications for both the palliative care and survivorship phases of care.
Guidelines for how cancer specialists and PCPs should optimally relate and communicate during various phases of the cancer care continuum are lacking. We believe these guidelines must consider disease site, cancer prognosis and treatment toxicity and must be in line with patient preferences and expectations. We recommend that PCPs and cancer specialists encourage patients to remain engaged with their PCPs during active cancer treatment via regularly scheduled visits. These visits should address ongoing management of comorbidities, long-term cancer or cancer treatment related symptom management, and the patient's understanding and satisfaction with their cancer care in the context of their global health and quality of life preferences. We specifically recommend visits with the PCP to follow the initial consultation with the cancer specialists, precede any major cancer operation (inpatient hospital stay, or as recommended by the cancer specialist), at regular intervals during active treatments, and at discharge from cancer specialist surveillance or transition to palliative care. We have proposed a preliminary conceptual model that can provide the framework for further investigations, elaboration, validation and guideline development (Figure 3 ). In this model, we propose that the relationship between PCP and cancer specialist is influenced by provider preferences, expectations, perceived competence and patient preferences, while the quality of communication is influenced by the content, mode and frequency of communication from cancer specialist to PCP. Together the relationship and communication influence the shared-care model. While we are not aware of any existing conceptual models for the PCP-cancer specialist relationship, this model does compare to a conceptual model that has been proposed for the inter-professional collaboration between OB physicians and midwives [52] . Both of these conceptual models emphasize trust, respect, communication, and role clarity.
Resistance to a shared-care or PCP-based model for survivorship and palliation by cancer specialists may become problematic as the number of cancer patients and survivors increases globally. For cancer survivorship, a long-term specialist-based model results in patients receiving specialty care despite being well; this may negatively impact access to cancer clinics that already face shortages of specialists. For palliative care, a specialist-based model may result in patients traveling frequently or over long distances and being outside of their support communities at a time when their performance status is poor and the need for psychosocial support is a priority. At least one barrier to a transition to a shared-or PCPbased model for palliation or survivorship is a real or perceived lack of oncology knowledge and experience by PCPs. It is unclear how much cancer specialists appropriately or inappropriately project necessary skills needed by PCPs. As suggested above, PCPs often feel they can competently follow and execute SCPs as well as recognize variations that require referral back to oncologists. There may be a misperception by cancer specialists that PCPs want to provide "cancer care" rather than "care for patients with cancer." We did note that PCPs often turned to Internet resources to address knowledge gaps. This finding suggests that these web-based resources should be provided by and/or vetted by major cancer organizations and provided in a format that meets the needs of the PCP. As the number of cancer patients on chronic active treatments and survivors increase, PCPs will need to become increasingly familiar with short and long-term treatment toxicities, surveillance and other aspects of survivorship care and many believe they can do this through teamwork with cancer specialists. Cancer organizations, health systems and specialists should aim to provide resources that are succinct and easily accessible to the PCPs caring for their patients. Primary care graduate medical education training programs should ensure exposure to cancer patients in various phases of the cancer continuum and cancer organizations should provide continuing medical education (CME) programs for PCPs who care for cancer patients and/or survivors.
Strengths and Limitations
Our review has exposed several important themes regarding the PCP-cancer specialist relationship as well as relevant gaps in the literature. The majority of the existing literature focuses on the survivorship phase of care only. Most of the studies reviewed also focused on the perceptions and needs of the PCP. Among studies that included cancer specialists, medical oncologists were the most common group sampled. One study specifically excluded surgeons working at National Cancer Institute (NCI) Community Cancer Center Programs, stating that the topic was less relevant to them [36] . Given these gaps in the literature, it is uncertain how these themes apply to the continuum of cancer care and care provided by other disciplines of cancer specialists such as surgeons and radiation oncologists and our conceptual model will be refined as future data become available.
As with any systematic review, our search was limited by the possibility of publication and search bias. To minimize these limitations we used broad and comprehensive search terms, searched multiple large databases, and hand-searched the references of included studies. Our findings are also limited by the available literature, and as previously noted the majority of the available literature sampled only medical oncologists instead of a broad range of cancer specialists, and many cancer types (outside of breast and colorectal cancer) are poorly represented. Finally, several of the included studies lacked key methodological details regarding sampling and analysis and thus it was difficult to judge the quality of the results.
Conclusion
In summary, these synthesized data inform a preliminary conceptual model and present a compelling rationale for further investigation and targeted strategies aimed at understanding and improving the PCP-cancer specialist relationship and communication throughout the cancer care continuum. A compelling confluence of views relative to the common goal of maximizing the care of cancer patients unites PCPs and cancer specialists, but how to optimize the relationship needs resolution. This review suggests that improving PCP-cancer specialist communication (especially from cancer specialist to PCP), establishing guidelines for provider roles during various phases of care to maximize the skill sets and needs of both PCP and cancer specialist, and providing well designed and timed oncology resources for PCPs may help achieve the shared goals of improving the quality and coordination of cancer care and enhancing patient and physician satisfaction. Table 3 Summary of Findings from the Quantitative Literature.
Recommendations to Improve Communication and Interaction Between PCPs and Cancer Specialists
Article
Participants
Study Design Findings
Blaauwbrock et al. [12] 233 PCPs Cross-sectional survey of PCPs attending a refresher course on survivorship care of adult survivors of pediatric cancer Ninety-seven percent (97%) of PCPs were willing to participate in a shared care model for follow-up. Sixty-four percent (64%) of PCPs felt that it was their responsibility to be in charge.
PCPs desired guidelines (64%), information about the patient's medical history (37%), and direct communication lines with oncologists (45%). Lack of communication was a barrier to shared care.
Cheung et al. [16] 255 PCPs 123 medical oncologists 232 PCP-oncologists pairs Cross-sectional survey of cancer survivors 2years from active treatment and NED and their self-identified PCP and oncologist Survivorship care expectations were most discrepant between PCPs and oncologists; patient-PCP expectations were more concordant than patient-oncologist expectations. Patient-oncologist discussions regarding survivorship improved patient-PCP expectations, but not PCP-oncologist concordance.
Smith et al. [18] 590 PCPs Cross-sectional survey of PCPs providing follow-up care for patients with nonmetastatic breast cancer PCPs were most confident in screening for recurrence and managing anxiety and least confident in managing lymphedema and providing psychosocial counseling. Most PCPs found discharge letters from oncologists to be helpful, particularly when including a treatment summary and recommendations for surveillance.
Potosky et al. [20] 1,072 PCPs 1,130 medical oncologists Cross-sectional survey of PCPs and medical oncologist identified via AMA Master file Compared with PCPs, oncologists were less likely to believe PCPs had the skills to conduct appropriate testing for breast cancer recurrence or to care for late effects of breast cancer. Only 40% of PCPs were confident in their knowledge of testing for recurrence.
Roorda et al. [21] 502 PCPs Cross-sectional survey of all PCPs in three northern provinces of the Netherlands Forty percent (40%) of PCPs were willing to accept exclusive responsibility of follow-up care sooner than 5 years after active cancer treatment. Perceived barriers included poor communication with cancer specialists, patient preference for specialist follow-up versus PCP, and PCPs lack of oncology knowledge.
Donohue et al. [22] 92 PCPs Cross-sectional survey of PCPs who were seeing survivors enrolled into a survivorship clinical trial Eighty-eight (88%) of PCPs regarded EMR generated SCPs as useful in communicating and coordinating care.
Babington et al. [25] 80 specialists 182 PCPs Cross-sectional survey of PCPs who had referred patients to an oncologist and the corresponding oncologist The majority (72%) of cancer specialists generated a letter following consultation, but only 58%
of Ezendam et al. [35] 266 PCPs Cluster randomized controlled trial of PCP practices Only a third of PCPs reported receiving SCPs. Those receiving SCPs were more likely to have communication with cancer specialists.
Salz et al. [36] 191 PCPs Cross-sectional survey of medical and radiation oncologist practicing at NCCCP sites A majority (87-89%) of oncology providers believed receiving a SCP was very important to the PCP, but 38% did not feel it was their responsibility to provide the SCP.
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Article
Participants
Study Design Findings
Merport et al. [38] 108 cancer specialists 400 PCPs Cross-sectional survey of cancer specialists and PCPs in Massachusetts Only 14% of cancer specialists reported preparing SCPs citing a lack of training, reimbursement and templates as barriers to use.
Cheung et al. [40] 255 PCPs 123 medical oncologists 232 PCP-oncologists pairs Cross-sectional survey of cancer survivors 2years from active treatment and NED and their self-identified PCP and oncologist PCPs and oncologists showed high discordance in perceptions of their own roles for primary cancer follow-up, cancer screening, and general preventative health (3%, 44% and 51% agreement rates, respectively).
Del Giudice et al. [42] 330 PCPs Cross-sectional survey of PCPs across Canada PCPs were willing to assume exclusive responsibility for follow-up care 2-3 years after active treatment,. The most useful modalities in assisting the transition were a letter from the specialist, printed guidelines, expedited re-referral and access to investigations when recurrence was suspected.
Salz et al. [43] 191 PCPs Cross-sectional survey of PCPs caring for colorectal cancer patients Most PCPs reported receiving too little information about the patients' clinical course and the oncologists plan for monitoring other cancers.
Hezewijk et al. [44] 130 cancer specialists (surgeons, medical, radiation oncologists) Cross-sectional survey of breast cancer members of a Dutch comprehensive cancer center Forty-four percent (44%) of breast cancer specialists believed a breast surgeon should always be involved in breast cancer follow-up, whereas only 9% believed a PCP should always be involved and 24% believed a PCP should never be involved.
Donnelly et al. [45] 256 breast cancer specialists Cross-sectional survey of breast specialist in the United Kingdom Breast cancer specialists viewed a "lack of PCP experience or training in oncology" and a "loss of patient outcome data" as barriers to early discharge to PCP follow-up.
Nissen et al. [46] 132 PCPs Cross-section survey of PCPs practicing in a single health system in the US Most (52%) PCPs were comfortable with responsibility for cancer surveillance. More than half rated transfer from oncologists to PCPs as fair or poor. PCPs endorsed uncertainty for the type and duration of surveillance testing which varied depending on cancer type.
Watson et al. [47] 100 oncologists 200 PCPs Cross-sectional survey of oncologist and PCPs who were members of doctors.net Less than half of PCPs were satisfied with aspects of communication with cancer specialists including the content of discharge letters and the ease of getting patients seen between routine appointments.
Forsythe et al. [ Table 4 Summary of Findings from the Qualitative Literature.
Article
Participants
Study Design Finding
Haq et al. [19] 8 PCPs 6 cancer providers Focus groups and in-depth interviews of patients, PCPs and cancer specialists PCPs expressed concerns with timeliness of information from cancer specialists and a lack of understanding/knowledge regarding cancer staging and SCPs.
DiCicco-Bloom et al. [23] 11 PCPs Interviews of PCPs in practices that employed at least one nurse practitioner and who cared for cancer patients PCPs find patient visits during cancer treatment important. They note differences in communication between community and academic oncologists and they develop strategies to obtain information to account for information deficits.
Mayer et al. [26] 5 PCPs Interviews of PCPs identified from a family practice listserv PCPs endorsed SCPs as helpful communication tools. If used alone, SCPs would be insufficient to ease the transition to follow-up care with PCPs. Improved communication and care coordination were identified as important for survivorship care.
Hewitt et al. [27] 20 oncologists (medical, radiation, urology, gynecology)
14 PCPs Focus groups and telephone interviews of providers identified at ASCO's annual meeting or through telephone recruitment PCPs viewed themselves as playing an important role during the post-treatment periods and indicated that a written care plan for follow-up would help them improve their survivorship care. Oncologists admitted rarely discharging their patients to PCPs for follow-up after active cancer treatment.
Sada et al. [28] 14 physicians (PCPs and medical oncologists) Cross-sectional semi-structured interviews of providers associated with and integrated health system Physicians reported EMRs improved communication within their system, but that communication across systems was difficult. PCPs expressed uncertainty regarding their role in the care of survivors, although medical oncologists emphasized PCPs their role in managing comorbidities.
Prouty et al. [30] 59 physicians (PCPs, oncologists, surgeons, gynecologists) Focus groups of a convenience sample of PCPs, medical, surgical and radiation oncologists Provider perceptions of the causes of communication breakdown in cancer care included issues related to providers and healthcare systems.
Rayman et al. [33] 11 PCPs Focus groups of PCPs from rural federally funded community health centers Providers' relationships were characterized as being with women with breast cancer and comprised an active behind-the-scenes role in supporting their patients through treatment decision and processes. Three themes emerged: knowing the patient, walking through treatment with them, and losing the patient to the system.
Rychetnik[34] 16 surgical oncologists
Interviews of surgical oncologists and dermatologist serving in melanoma units in Australia Cancer specialists utilize various models of shared care dependent on their preferences and those of the patients.
Kantsiper et al. [37] 15 PCPs 16 cancer specialists Focus groups of PCPs and oncology providers from Johns Hopkins Community Physician Network Specialists struggle with discharging survivors due to protective relationships. PCPs expressed concerns over time and training to provide survivorship care, and communication with oncologists.
O'Brien et al. [39] 18 PCPs Interviews of PCPs participating in a randomized controlled trial evaluating SCPs Most PCPs were comfortable providing breast cancer survivorship care 3-5 years after diagnosis, but desired timely and informative communication from oncologists.
Shalom et al. [41] 15 PCPs Interviews of UCLA-affiliated PCPs who had previously received a SCP PCPs were more confident and prepared for survivorship care after receiving a SCP.
PCPs reported a willingness to accept either sole or shared responsibility for routine follow-up care. Table 5 Summary of Findings from the Mixed Methods Literature.
Article
Study Design
Finding Dulko et al. [17] 39 PCPs Cross-sectional survey of PCPs who received an SCP; interviews of oncology providers Sixty-four percent (64%) of PCPs cited limited access to survivors, 58% cited insufficient knowledge of cancer survivor issues, and 49% cited inadequate recommendations by oncologists. Oncology providers cited barriers to providing SCPs including lack of time, poor reimbursement, and lack of guidelines.
Shen et al. [24] 18 PCPs (qualitative)
128 PCPs (quantitative) Interviews and cross-sectional surveys of PCPs practicing in underserved minority communities There is a gap in PCP-oncologist communication occurring between diagnosis and treatment. PCPs wanted more communication with oncologists, updates on their patient's prognosis throughout treatment, and to be contacted via telephone or email. PCPs saw their roles as crucial in providing supportive care for their patients.
Jefford et al. [50] 81 PCPs Focus groups and surveys of PCPs in an randomized controlled trial evaluating faxed tailored chemotherapy information PCPs in the intervention group demonstrated significantly greater increase in confidence and satisfaction compared to usual care, reflecting a 7.1% and 10.5% difference in score.
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